Should iron tablets be given to a pregnant woman with thalassemia?

Iron Supplementation in Pregnant Women with Thalassemia

Iron tablets should generally be given to pregnant women with thalassemia minor (trait) when iron deficiency is present, but should NOT be given to women with transfusion-dependent thalassemia major due to their existing iron overload.

Critical Distinction: Type of Thalassemia Matters

The answer depends entirely on which type of thalassemia the pregnant woman has:

Thalassemia Minor (Trait) - Iron Supplementation IS Recommended

For pregnant women with beta-thalassemia minor, iron supplementation should be provided as part of standard antenatal care 1, 2, 3. This contradicts the common misconception that thalassemia trait patients should avoid iron.

Key Evidence:

• A 1975 study demonstrated that pregnant women with beta-thalassemia trait who received iron for >12 weeks maintained stable hemoglobin levels throughout pregnancy, while those receiving iron for <12 weeks experienced significant hemoglobin drops (P<0.001) 3
• Bone marrow biopsies in these patients at 32 weeks showed deficient iron stores despite having thalassemia trait 3
• Recent 2022 research confirms that iron supplementation in pregnant women with beta-thalassemia minor combined with iron deficiency anemia is both effective and safe, with hepcidin functioning normally to maintain iron homeostasis 2
• A 2025 study found no evidence of iron overload in thalassemia minor patients during pregnancy; instead, iron deficiency commonly coexists 1

Clinical Algorithm for Thalassemia Minor:

• Screen for coexisting iron deficiency if hemoglobin <11.5 g/dL (sensitivity 79.8%, specificity 82.6%) 4
• Check ferritin levels and iron studies
• Provide iron supplementation when iron deficiency is documented
• Continue iron throughout pregnancy as standard antenatal care 1, 3

Thalassemia Major - Iron Supplementation is CONTRAINDICATED

For pregnant women with transfusion-dependent thalassemia major, iron supplementation should be avoided due to pre-existing iron overload from chronic transfusions 5.

Critical Management Points:

• These patients already have significant iron overload from regular blood transfusions
• Assess cardiac T2* MRI and cardiac function before conception to evaluate iron-related organ damage 5
• Blood consumption increases during pregnancy to maintain hemoglobin ≈10 g/dL 5
• Iron chelation therapy must be interrupted during pregnancy due to teratogenic concerns 5
• In patients with severe heart or liver iron overload, consider restarting iron chelation with deferoxamine toward the end of the second trimester 5
• Monitor cardiac function carefully throughout pregnancy, as cardiac complications occur in 1.1-15.6% of pregnancies 5

Common Pitfalls to Avoid

1. Assuming all thalassemia patients have iron overload: Thalassemia minor patients frequently have iron deficiency, not overload 1, 4

2. Withholding iron from thalassemia trait carriers: This outdated practice leads to worsening anemia during pregnancy 3

3. Not distinguishing between thalassemia minor and major: These require opposite approaches to iron management

4. Relying solely on hemoglobin electrophoresis: Check ferritin and iron studies to identify coexisting iron deficiency 4

5. Missing the 31% of thalassemia minor patients who have concurrent iron deficiency 4

Monitoring Recommendations

For thalassemia minor with iron supplementation:

• Monitor hemoglobin and ferritin levels throughout pregnancy
• Iron supplementation does not lead to iron overload 1
• Hepcidin levels remain appropriately regulated 2

For thalassemia major during pregnancy:

• Cardiac monitoring is essential (cardiac complications range 1.1-15.6%) 5
• Manage in expert centers with multidisciplinary teams 5
• Thromboembolism prophylaxis with heparin/LMWH, especially if splenectomized 5